Cambridge Nutraceuticals
www.camnutra.comWe create supplements as they should be – easy to absorb, with proven clinical benefits. Our first product, ATERONON HEART+, was developed through £12 million in research funding and was clinically tested at Cambridge University Hospital NHS Foundation Trust to prove its effectiveness. Every Cambridge Nutraceuticals product is the focus of multiple clinical trials and is manufactured using the highest quality ingredients. TURMERIC+, the most popular of our Joint Health supplements and the focus of significant press coverage, is now supported by 41 published studies. Based in Cambridge, the world-famous research hub, Cambridge Nutraceuticals was founded in 2012 and has grown rapidly, winning the confidence of customers, investors and internationally renowned research groups. We sell direct-to-customer within the UK and reach international purchasers through our overseas distributors, with Australia being an especially important market.
Read moreWe create supplements as they should be – easy to absorb, with proven clinical benefits. Our first product, ATERONON HEART+, was developed through £12 million in research funding and was clinically tested at Cambridge University Hospital NHS Foundation Trust to prove its effectiveness. Every Cambridge Nutraceuticals product is the focus of multiple clinical trials and is manufactured using the highest quality ingredients. TURMERIC+, the most popular of our Joint Health supplements and the focus of significant press coverage, is now supported by 41 published studies. Based in Cambridge, the world-famous research hub, Cambridge Nutraceuticals was founded in 2012 and has grown rapidly, winning the confidence of customers, investors and internationally renowned research groups. We sell direct-to-customer within the UK and reach international purchasers through our overseas distributors, with Australia being an especially important market.
Read moreCountry
City (Headquarters)
Cambridge
Industry
Employees
11-50
Founded
2012
Social
Employees statistics
View all employeesPotential Decision Makers
Investor
Email ****** @****.comPhone (***) ****-****Seed Investor
Email ****** @****.comPhone (***) ****-****